Our Leadership
Dvir Cohen has served as Momentis Surgical’s Chief Executive Officer since October 2013. Mr. Cohen has been a leader in Momentis from its inception and brings more than 15 years of experience in innovative robotic systems. Prior to joining Momentis Surgical, Mr. Cohen served in various positions in the Israeli Ministry of Defense as an awarded officer specializing in robotic systems for various applications. From 2011 to 2013, Mr. Cohen held the positions of research and development manager and robotic project specialist in an elite technology unit of the Israel Intelligence Force. From 2007 to 201, Mr. Cohen led several opto-mechanical disruptive solutions in the Ministry of Defense, one of which won the Israel Defense Award. Mr. Cohen has experience at all stages of product development, from the early conceptual stage through prototyping to production line implementation and final marketing of government and defense units. Mr. Cohen’s recent recognitions include receiving the Deal of the Year Award from BioFlorida, a life sciences industry association, for Momentis Surgical’s $96 million Series D financing and being named an Endeavor Entrepreneur by Endeavor Miami, an affiliate of the global Endeavor organization leading the global high-impact entrepreneurship movement. Mr. Cohen earned an MBA from the Recanati Business School at Tel Aviv University, majoring in Business Strategy and Entrepreneurship. He also earned a Bachelor of Science and a Master of Science degree in mechanical engineering from the Technion as part of the “Brakim” excellence program.
Maya Leib has led Regulatory and Quality at Momentis since September 2023. Maya brings deep experience in quality and regulatory at medical devices companies. As senior consultant in MedicSense (former consultancy company), Maya implemented and maintained quality management system in various medical devices companies, prepared and represented the companies in audits. In addition, Maya planned the regulatory strategy and led companies towards regulatory approval. Maya is certified Manager of Quality and Organizational Excellence (ICMQ) by the Israeli Society for Quality (ISQ) and certified Lead Auditor by BSI. Maya earned M.Sc degree in Technology Management and B.Sc degree in Electronic Engineering from Holon Institute of Technology.
Board of Directors
Sandra Morgan has served as a Momentis Surgical director since August 2022. Ms. Morgan has 32 years of healthcare and executive leadership experience working for Fortune 100 companies. Most recently, she served as senior vice president, physician and provider relations at HCA Healthcare from March 2008 until June 2021. During her 13-year tenure at HCA, her responsibilities included business growth for hospitals, ambulatory surgery centers, urgent care clinics, transfer centers, and all service lines including surgical and robotics, women’s and children’s, neurology, oncology, emergency services, behavioral health, employer brokers, and rural markets. She also led the HCA Enterprise Transfer Center and founded the management development group that helped advance the careers of many of HCA’s vice presidents, hospital CEOs, COOs, and service line leaders. Prior to HCA, Ms. Morgan served as vice president for Pfizer’s U.S. managed care business, where she played a major role in the launch and formulary adoption of several products. Ms. Morgan received her BS degree in business administration from the University of Illinois and an MBA from St. Joseph’s University.
Dr. Moll has served as a Momentis Surgical director since July 2023. Dr. Fred Moll is an icon in the medtech industry and has been called “the father of robotic surgery”. In 1995 Dr. Moll co-founded Intuitive Surgical, Inc., and served as its first Chief Executive Officer. Dr. Moll was also a co-founder, and, from September 2012 to 2019, was the Chairman and Chief Executive Officer of Auris Health, Inc., a robotics medical device company, that was acquired by Johnson and Johnson in 2019. From April 2019 to March 2023, Dr. Moll served as Chief Development Officer for Johnson & Johnson Medical Devices Companies. Dr. Moll is also the Founding Partner of Sonder Capital Management, LLC, a healthcare venture capital investment firm. Dr. Moll holds a B.A. degree in economics from the University of California at Berkeley, a M.S. degree in management from Stanford University, and a M.D. from the University of Washington. He currently serves on the boards of several healthcare companies, including Procept BioRobotics, Inc., ShockWave Medical, Avail Medsystems, and RefleXion Medical, Insightec, Moon Surgical and SS Innovations.
Mr. Stansky has served as a Momentis Surgical director since July 2023. Mr. Stansky was a Managing Director of Tudor Investment Corporation where he was responsible for long/short equity, crossover, and venture capital investments. He helped establish Tudor’s equity investment group in 1994 and retired from active investment management in 2008. From 1985 to 1994, Mr. Stansky was an analyst and portfolio manager at Wellington Management Company. Board directorships: Insightec Corp., OrthoSensor, MAKO Surgical Corp., and TransMedics, Inc. Mr. Stansky has Certified Public Accountant and Chartered Financial Analyst designations and holds a B.A. in Accounting from the University of Massachusetts and a M.B.A. from Harvard Business School.
Dr. Morry Blumenfeld has served as a Momentis Surgical board observer since February 2016. Dr. Blumenfeld is president and CEO of Quescon Consultants, Ltd., a medical device consulting company, and a partner at Meditech Advisors, LLC. He was an executive at GE for nearly 35 years, and served GE Medical Systems Business in numerous roles, including initiating both the CT and MRI businesses, and as managing director of GE Medical Systems in Israel. Dr. Blumenfeld holds five patents and serves or has served on the boards of a number of medical device and technology companies in the USA and Israel – as well as numerous Canadian, international, and Israeli advisory boards in technology and science. He is on the board of the Hebrew University and Yissum (the Hebrew University’s tech transfer company), and on the scientific advisory board of the Momentum Fund of Ramot (Tel Aviv University’s tech transfer company). Dr. Blumenfeld received his undergraduate degree and Ph.D from the University of Toronto.